Advertisement

Reactions Weekly

, Volume 1756, Issue 1, pp 42–42 | Cite as

Antineoplastics

Acquired resistance in lung adenocarcinoma: case report
Case report
  • 43 Downloads

Reference

  1. Hu Y, et al. Tyrosine kinase inhibitor acquired resistance mechanism alternates between EGFR and ALK in a lung adenocarcinoma patient. Thoracic Cancer 10: 1252-1255, No. 5, May 2019. Available from: URL: http://doi.org/10.1111/1759-7714.13015 - China

Copyright information

© Springer International Publishing AG 2019

Personalised recommendations